The CVBF has launched and collaborates to the management of drug databases and registries such as:
Database of medicines for children – European Paediatric Medicines Database – EPMD (Teddy Network)
It is a database containing information (indication, dosages, age of use, clinical studies, etc.) on paediatric drugs authorised by EMA under the centralised procedure. It is aimed to create a harmonised, integrated and reliable European source of information by collecting data from different sources (national authorities, regulatory bodies, pharmaceutical companies).
It is a useful instrument to provide all the stakeholders with appropriate information concerning the rational use of paediatric medicines and to identify unmet medical needs in paediatrics: healthcare professionals, institutional bodies, companies, patients’ associations and families can freely access to the database.
Database of drugs for rare diseases – EuOrphan (EuOrphan Project)
It is a free and regularly updated database containing information from official sources on drugs available on the market or in development in Europe and in US for rare diseases, including “orphan drugs” (ODs) designated and marketed by EMA and the Food and Drug Administration (FDA) respectively. A new database version will be available on a restructured website.
Inventory of procedures for obtaining Paediatric Clinical Trial approvals (Teddy Network)
It contains information on the relevant local requirements and procedures to carry out the Clinical Trial Application in European and non-European countries;
Interregional Registry for thalassemia patients (Italian Health Ministry Project, art.12)
It includes epidemiological, clinical, diagnostic and therapeutic data on about 2,000 thalassaemia patients as well as technology assessment data on methods to evaluate iron overload in order to obtain data for the planning of services and expense reduction.